Abstract:Background Although surgical resection or amputation has been the mainstay of localized chondrosarcoma management for many decades, its efficacy in patients with metastatic chondrosarcoma remains unknown, and likewise we do not know whether there are any tumor-or patient-related factors associated with better survival after surgery for metastatic chondrosarcoma. Questions/purposes (1) Is resection of the primary tumor associated with improved survival in patients with metastatic chondrosarcoma? (2) Which subgroups of patients with chondrosarcoma benefit more from resection in terms of survival? Methods We identified 200 of 222 patients with metastatic chondrosarcoma in the Surveillance, Epidemiology, and End Results (SEER) database between 1988 and 2014 based on the exclusion criteria. Among those patients, 107 (53.5%) underwent primary tumor resection or amputation. Patient information, including demographics (patient age, gender, race, year of diagnosis), tumor characteristics (primary site, histologic subtype, tumor grade, tumor size), and treatment (record of operation and radiation), was collected and included in the study. Kaplan-Meier analyses, log-rank tests, competing risks framework, multivariable Cox regression modeling, and interaction tests were conducted to assess the association of primary tumor resection and survival in the overall cohort and subgroups. Results Resection of the primary tumor was associated with improved overall survival (hazard ratio [HR], 0.481; 95% confidence interval [CI], 0.340-0.680; p < 0.001) and cancer-specific survival (HR, 0.493; 95% CI, 0.343-0.709; p < 0.001) after controlling for confounding variables. After controlling further for age, histologic subtype, and grade, primary tumor resection was associated with a survival advantage in patients with conventional subtype and Grade II chondrosarcoma (conventional subtype: HR, 0.403; 95% CI, 0.260-0.623 for overall survival and HR, 0.396; 95% CI, 0.250-0.627 for cancer-specific survival). However, primary tumor resection was not associated with increased survival in patients with metastatic chondrosarcoma who had the dedifferentiated subtype and Grade III malignancy. Conclusions The present study demonstrates a possible favorable association between primary tumor resection and survival in some patients with metastatic chondrosarcoma at initial diagnosis. Specifically, patients with conventional subtypes and Grade II malignancies who underwent primary tumor resection had better survival compared with those patients who did not have primary tumor resection. Thus, there might be a benefit from primary tumor resection in these patients, but given the limitations of this database, further prospective studies or randomized trials are needed to confirm our findings. In the meantime, this information might be helpful to consider when discussing surgical options with patients who have conventional, Grade 2 metastatic chondrosarcoma at diagnosis. Level of Evidence Level III, therapeutic study.

Optimal timing of re‐excision in synovial sarcoma patients: Immediate intervention versus waiting for local recurrence

Clinical outcomes associated with re-excision after unplanned excision or re-excision after local recurrence in patients with nonmetastatic synovial sarcoma

Does Resection of the Primary Tumor Improve Survival in Patients With Metastatic Chondrosarcoma?

Unplanned Excision of Synovial Sarcoma: Factors Associated with Recurrence and Survival

Whether unplanned excision on synovial sarcoma will influence the prognosis? An retrospective analysis of prognostic factors in 54 synovial sarcoma cases at a single center

The efficacy of re-excision after unplanned excision for synovial sarcoma

Clinical Significance and Risk Factors of Local Recurrence in Synovial Sarcoma: A Retrospective Analysis of 171 Cases

Prognostic Improvement of Reexcision for Positive Resection Margins in Patients with Advanced Gastric Cancer.

Efficacy of Re-Excision for 78 Cases with Soft Tissue Sarcoma

The impact of margins and re-resection in pediatric synovial sarcoma

Evaluation of Prognostic Factors for Synovial Sarcoma

Role of perioperative chemotherapy for high-grade synovial sarcoma: a retrospective study of a single Asian cohort in China

Unplanned Excision of Extremity and Trunk Wall Soft Tissue Sarcoma: To Re-resect or Not to Re-resect?

Efficacy of perioperative chemotherapy for synovial sarcoma: a retrospective analysis of a Nationwide database in Japan

Efficacy of Neoadjuvant Chemotherapy for Synovial Sarcoma: Retrospective Analysis of a Nationwide Database in Japan

Outcome of Patients with Osteosarcoma after Recurrence and Analysis of Factors Affecting the Long-Term Survival——a Long-Term Follow-Up Study of Recurrent Patients by Multicenter

Comparation of Non-Intralesional or Intralesional Spondylectomy for Chondrosarcoma in Mobile Spine: a Retrospective Study of Surgery Management, Complications, and Prognosis.

Operative intervention for recurrence of adrenocortical carcinoma: A single-center experience

Reoperation With Total Hysterectomy After Incomplete Surgery Is Helpful In Patients With Incidentally Diagnosed Uterine Leiomyosarcoma

Planned and Unplanned Sarcoma Resections: Comparative Analysis of Local Recurrence, Metastasis, and Mortality

Clinicopathological Profile and Survival Outcomes in Patients with Localised Extremity Synovial Sarcomas